Pretreatment with GLP-1(2836) increases glycolysis and glucose oxidation, and decreases FAO in coronary vascular cells
Weight-based dosing calculations sometimes appear in discussions, with suggestions of approximately 2.5 to 5 mcg per pound of body weight daily
PlexusDx's Precision Peptide Genetic Test identifies how your unique genetic profile influences GLP-1 receptor responsiveness and peptide metabolism, allowing providers to optimize your treatment plan from the start
Tirzepatide activates both GLP-1 and GIP receptors, potentially offering broader metabolic effects for patients with certain genetic profiles
Radiotherapy and the gut microbiome: facts and fiction
While this test was designed for peptide-pathway insights, the genetic variants we assess overlap with glutathione metabolism, melanin regulation, and cellular resilienceinformation that should be interpreted with a qualified healthcare provider